Placebo -Topical Film Forming Solution without VP-102

COMBINATION_PRODUCT2 trials

Sponsors

Verrica Pharmaceuticals Inc.

Conditions

Molluscum Contagiosum

Phase 3

Cantharidin Application in Molluscum Patients

CompletedNCT03377803

Verrica Pharmaceuticals Inc.Molluscum Contagiosum

Start: 2018-02-14End: 2018-09-26Updated: 2021-12-14

Cantharidin Application in Molluscum Patients-1

CompletedNCT03377790

Verrica Pharmaceuticals Inc.Molluscum Contagiosum

Start: 2018-03-21End: 2018-11-26Updated: 2022-01-11

Related Papers

Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.

2021-02-185 citations

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum

JAMA Dermatology2020-09-2330 citations